| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7M | -19.9% | -43.2% |
| R&D Expense | $3.3M | +1.5% | -35.1% |
| SG&A Expense | $10.7M | +17.9% | +14.7% |
| Operating Income | -$16.9M | -13.1% | +47.7% |
| Pre-tax Income | -$16.3M | -29.1% | +55.4% |
| Income Tax | $78K | -35.0% | -66.2% |
| Net Income | -$16.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $34.1M | -3.5% | -39.6% |
| Accounts Receivable | $15.5M | -13.2% | -13.3% |
| Inventory | $635K | -7.6% | -35.9% |
| Current Assets | $84.1M | -17.2% | -40.5% |
| Total Assets | $327.3M | -6.0% | -18.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.9M | — | — |
| Capital Expenditures | $21.1M | — | — |
| Investing Cash Flow | $7.9M | — | — |
| Financing Cash Flow | -$6.0M | — | — |
| Free Cash Flow | -$45.0M | — | — |
| -28.5% |
| +55.4% |
| EPS (Basic) | -$0.11 | -22.2% | +57.7% |
| EPS (Diluted) | -$0.11 | -22.2% | +57.7% |
| $13.3M |
| -16.6% |
| +52.9% |
| Total Liabilities | $32.4M | -13.1% | -20.5% |
| Stockholders' Equity | $295.0M | -5.2% | -17.8% |